Medicament for treating cerebral infarction and preparation method thereof

Abstract

The invention discloses a medicament for treating cerebral infarction and a preparation method thereof. The invention aims to overcome the defects of single medicament treatment target spot, difficulty in treating blood and blood vessels simultaneously, easiness in causing drug tolerance, remarkable side effect and the like existing in the conventional treatment of cerebral infarction. The medicament consists of the following raw materials by weight: 60g of astragalus, 10g of red paeony root, 10g of szechuan lovage rhizome, 20g of Chinese angelica, 15g of earthworm, 5g of leech, 2 long-nosed pit vipers, 15g of peach kernel, 15g of safflower, 8g of scorpio, 10g of rhizoma pinellinae praeparata, 15g of tall gastrodia tuber, 15g of red-rooted salvia root, 30g of siegesbeckia orientalis, 2 centipedes and 5g of pseudo-ginseng root. The medicaments are ground into powder, the power is filled into capsules, and four capsules are taken at one time for three times every day. The medicament is mainly used for treating cerebral infarction. As proved by treatment on 275 samples, the effective rate of the medicament is 98.6 percent.

Description

technical field [0001] The invention relates to a medicine for treating cerebral infarction and a preparation method thereof. Background technique [0002] There are nearly 6 million patients with cerebral thrombosis (stroke) in my country. With its high incidence, high disability rate, high recurrence rate, high mortality rate and many complications, it has truly become the "first killer" of human health! The treatment of stroke hemiplegia has always been a major problem in medicine. For a long time, it has been aimed at thrombolysis and refreshing the brain. "Bi resistance" is the long-term root cause of apoplexy, and it is difficult to achieve the expected curative effect with simple western medicine treatment. [0003] Although the treatment of cerebral infarction with western medicine has the advantages of quick onset and strong treatment pertinence, the target of western medicine is single, and it is difficult to achieve the purpose of treating blood and blood vessels...

AI Technical Summary

Problems solved by technology

[0002] There are nearly 6 million patients with cerebral thrombosis (stroke) in my country. With its high incidence, high disability rate, high recurrence rate, high mortality rate and many complications, it has truly become the "first killer" of human health! The treatment of stroke hemiplegia has always been a major problem in medicine. For a long time, it has been aimed at thrombolysis and refreshing the brain. "Bi resistance" is the long-term root cause of stroke, and it is difficult to achieve the expected curative effect with simple western medicine treatment

[0003] Although the treatment of cerebral infarction with western medicine has the advantages of quick onset and strong treatment pertinence, the target of western medicine is single, and it is difficult to achieve the purpose of treating blood and blood vessels at the same time as modern traditional Chinese medicine with a large compound formula made from authentic materials, while cerebral infarction It is the result of the combined effect of blood lesions (high blood viscosity, high blood lipids, etc.) and vascular lesions (atherosclerotic plaque formation, stenosis of the lumen, etc.)

And most western medicines, including aspirin, will produce different drug resistance; and most western medicines have obvious side effects, so it is not suitable for long-term treatment for middle-aged and elderly patients with cerebral infarction to prevent recurrence